Short answer
An EU prospectus is generally required before securities are offered to the public in the Union or admitted to trading on an EU regulated market. These are separate triggers: a private placement may avoid the public-offer trigger but still need a prospectus for regulated-market admission, while an offer can be public even if no regulated-market listing is planned.
Important exemptions apply. They include offers solely to qualified investors, offers to fewer than 150 non-qualified persons per Member State, certain high-denomination or high-commitment offers, specified employee or restructuring transactions, and defined follow-on issuances. Since 5 June 2026, an offer below an aggregate EUR 12 million per issuer or offeror over 12 months is exempt, although a Member State may instead use a EUR 5 million threshold. A national information document can still be required.
Where a prospectus is published, responsible persons must be identified and the document must not contain material inaccuracies or omissions. Article 11 requires Member States' civil-liability rules to apply to the responsible persons. EU law identifies a minimum responsibility structure, but national law determines fault, reliance, causation, recoverable loss, limitation and remedies.
Test the public offer and listing separately
The Prospectus Regulation defines an offer to the public broadly as a communication, in any form and by any means, presenting enough information about the offer terms and securities to enable an investor to decide whether to purchase or subscribe. Website invitations, app flows, presentations and intermediary placements can qualify; “private round” is not a legal conclusion.
The current general rule is:
Securities may be offered to the public in the Union only after prior publication of a prospectus, subject to the Regulation's exemptions. —
Separately, admission to trading on a regulated market generally requires prior publication. Admission to an MTF or SME growth market is not automatically regulated-market admission, but a connected public offer may still trigger the offer rule. The precise venue classification matters.
The Regulation excludes some securities entirely, including specified sovereign and central-bank instruments and units of open-ended collective investment undertakings. Other transactions remain within scope but receive an exemption from publishing. That distinction affects voluntary prospectuses, advertising and later resale.
Exemptions depend on transaction facts
Common public-offer exemptions include:
- an offer addressed solely to qualified investors;
- an offer addressed to fewer than 150 natural or legal persons per Member State, excluding qualified investors;
- securities with a denomination per unit of at least EUR 100,000;
- offers where each investor acquires at least EUR 100,000 per separate offer; and
- defined exchanges, mergers, employee offers, dividends and fungible follow-on issuances, sometimes conditional on a shorter information document.
An exemption at the first placement does not necessarily cover resale. A later public resale or regulated-market admission needs its own analysis. Financial intermediaries also need written consent to use an issuer's valid prospectus where the Regulation's resale conditions are relied on.
Since 5 June 2026, Article 3 exempts a public offer where the total aggregated consideration in the Union is below EUR 12 million per issuer or offeror over 12 months and the offer is not passported under Article 25. A Member State may use a lower EUR 5 million threshold instead. The calculation covers types and classes of securities and other ongoing or recent offers, subject to the Regulation's specified exclusions from aggregation.
The exemption does not mean “no disclosure”. The Member State may require a national document no more extensive than the EU provision permits. Offers in several states require checking each state's threshold choice and whether a passported prospectus is more practical.
Regulated-market admission has its own exemptions
Article 1(5) covers admission exemptions, including certain securities fungible with an existing admitted class. The Listing Act raised and restructured some follow-on limits and introduced routes using a short Annex IX document where conditions are met, including trading history and absence of restructuring or insolvency proceedings.
These are technical conditions, not a general “already listed” exemption. The 12-month percentage, fungibility, market history, transaction purpose and required filing must all be verified. Combining exemptions cannot be used to evade the applicable cap.
An issuer can also publish a voluntary prospectus for an exempt offer or admission. Once approved as a prospectus under the Regulation, the associated rules—including responsibility—apply.
What the prospectus must achieve
The prospectus must contain material information necessary for investors to make an informed assessment of the issuer and any guarantor, their rights and prospects, the securities, and the reasons for and impact of the issuance. The exact annexes and format depend on equity or non-equity status, issuer history and the available standard, follow-on or EU Growth issuance regime.
The 2026 technical layer is now operative. supplies reduced content and standardised formats for EU Follow-on and EU Growth issuance prospectuses. updates classification, exemption-document and incorporation-by-reference rules. Transaction teams should use the current annexes, not pre-Listing Act templates.
Risk factors must be specific and material, not a catalogue of generic possibilities. The summary is short and structured, but it cannot repair omissions in the main document. Advertisements must be identifiable and consistent with the prospectus.
Approval by the home competent authority is scrutiny for completeness, consistency and comprehensibility. It is not a statement that the securities are a good investment, that every fact is true, or that the authority guarantees the issuer. Liability disclaimers cannot neutralise the statutory responsibility regime.
New information may require a supplement
A significant new factor, material mistake or material inaccuracy arising or discovered during the relevant offer/admission period must be addressed through a prospectus supplement if it could affect assessment of the securities. The supplement follows approval and publication rules.
Investors who agreed to acquire before publication of a qualifying supplement may have a withdrawal right within the statutory period where the trigger arose before the offer closed or securities were delivered, whichever occurs first. The exact current Article 23 conditions and any Listing Act transition should be checked against the offering timetable.
Silence is therefore risky even where the original document was accurate when approved. The issuer needs a live escalation process for financial deterioration, litigation, regulatory events, forecast changes and other potentially material developments.
Who can be responsible?
Article 11 requires responsibility for prospectus and supplement information to attach at least, as applicable, to the issuer or its administrative, management or supervisory bodies, the offeror, the person seeking regulated-market admission, or the guarantor. Responsible persons must be named and declare that, to the best of their knowledge, the information accords with the facts and omits nothing likely to affect its import.
Member States must ensure that their civil-liability rules apply to the persons responsible for the information given in the prospectus. —
This is not a fully harmonised EU damages formula. The competent national law determines the claimant, standard of fault, reliance or transaction connection, causation, measure of loss, joint responsibility, defences and limitation. EU principles of equivalence and effectiveness constrain national procedure.
Liability cannot attach solely on the summary unless, read with the rest of the prospectus, it is misleading, inaccurate or inconsistent, or omits key information needed to help investors decide. That protection does not shield responsibility for defects in the full prospectus.
Qualified investors are not always excluded from claims
In Bankia, the Court of Justice interpreted the predecessor Prospectus Directive in a mixed offer to retail and qualified investors. It held:
An action for damages on the prospectus information could be brought “not only by retail investors but also by qualified investors”. —
The ruling did not decide the national damages claim. It also allowed national law, consistently with equivalence and effectiveness, to take account of a qualified investor's knowledge—or expected knowledge—of the issuer obtained through its relationship with the issuer outside the prospectus.
The judgment concerned Directive 2003/71, but its reasoning helps explain the current architecture: an exemption for an offer made solely to qualified investors does not make published prospectus information irrelevant to qualified investors in a mixed offer.
A practical pre-launch checklist
- Classify the instrument as a security within the Regulation.
- Map every communication, audience and Member State in the offer.
- Test public-offer and regulated-market-admission triggers separately.
- Aggregate consideration and follow-on issuance percentages over the correct 12-month period.
- Check the relevant Member State's EUR 12 million or EUR 5 million threshold choice and national document rules.
- Confirm every exemption condition and the consequences of later resale.
- Identify responsible persons and build verification records for material statements and omissions.
- Maintain an escalation process for supplements and withdrawal rights.
- Confirm approval, publication, passport, language and advertising steps before launch.
Conclusion
The Prospectus Regulation starts with two broad triggers—public offer and regulated-market admission—then applies transaction-specific exclusions and exemptions. Current small offers below EUR 12 million are exempt at EU level unless the relevant Member State uses the EUR 5 million option, but aggregation and national disclosure still matter.
When a prospectus is published, named transaction actors bear responsibility under Article 11 and Member State civil-liability law. Approval is not a warranty. Accurate initial drafting, documented verification and prompt supplementation are the core controls against liability for misleading statements or material omissions.
Sources
This article provides general legal information, not advice for a specific matter. Laws, facts and procedural deadlines may change the result. Follow the linked primary sources and obtain local advice before acting.